Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 113 publications
Cost-effectiveness of frontline eltrombopag with immunosuppressive therapy for severe aplastic anemia.
Journal: Blood. Red cells & iron
Published: May 04, 2026
Real-World Overall Survival and Time to Next Treatment Among Medicare Beneficiaries with Chronic Lymphocytic Leukemia in the Frontline Setting.
Journal: Cancers
Published: April 27, 2026
HSR26-253: Patient Assistance for Drug Cost Sharing: Highlighting the Variability Across Pharmaceutical Manufacturers of Specialty Oral Anticancer Medications for Blood Cancers.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 16, 2026
HSR26-253: Patient Assistance for Drug Cost Sharing: Highlighting the Variability Across Pharmaceutical Manufacturers of Specialty Oral Anticancer Medications for Blood Cancers.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 31, 2026
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 13, 2026
Perceived Value of Transfusion Access and Hospice Services Among Patients With Blood Cancers.
Journal: JAMA network open
Published: November 05, 2025
Feasibility, safety and outcomes of patients with newly diagnosed acute myeloid leukemia discharged 'early' after intensive induction.
Journal: Leukemia & lymphoma
Published: October 29, 2025
Weekly dosing schedule of brentuximab vedotin is well tolerated in mycosis fungoides/Sézary syndrome.
Journal: British journal of haematology
Published: May 13, 2025
Real-World Treatment Patterns After Discontinuation of Venetoclax or BTKis in the Frontline Setting Among Older Adults With Chronic Lymphocytic Leukemia.
Journal: JCO oncology practice
Published: December 20, 2024
Last Updated: 09/26/2026